US Physicalrapy Inc (USPH)

Return on equity (ROE)

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Net income US$ in thousands 31,424 28,239 32,158 40,831 35,194
Total stockholders’ equity US$ in thousands 488,929 476,194 315,793 295,606 276,160
ROE 6.43% 5.93% 10.18% 13.81% 12.74%

December 31, 2024 calculation

ROE = Net income ÷ Total stockholders’ equity
= $31,424K ÷ $488,929K
= 6.43%

The return on equity (ROE) of US Physicalrapy Inc has displayed fluctuations over the five-year period from 2020 to 2024. Initially, in December 2020, the ROE stood at 12.74%. Subsequently, there was an increase in the ROE to 13.81% by December 2021, indicating improved profitability relative to shareholder equity.

However, from December 2021 to December 2022, there was a decline in the ROE to 10.18%, suggesting a reduction in the firm's ability to generate profits from its equity base. This downward trend continued as the ROE dropped further to 5.93% by December 2023.

In the latest period, December 2024, there was a slight recovery in the ROE to 6.43%, but it remained below the levels observed in the earlier years. Overall, the declining trend in the ROE over the period reflects challenges in maintaining or enhancing profitability relative to the shareholders' equity in US Physicalrapy Inc.


Peer comparison

Dec 31, 2024

Company name
Symbol
ROE
US Physicalrapy Inc
USPH
6.43%
Privia Health Group Inc
PRVA
4.11%